MSB 3.21% $1.13 mesoblast limited

Cell Therapy News/Articles, page-9843

  1. 26 Posts.
    lightbulb Created with Sketch. 13
    Sorry if already posted.

    Published yesterday, and makes a few references to some of our trials.

    https://www.mdpi.com/2077-0383/10/13/2991/pdf

    "Alloreactive Immune Response Associated to Human Mesenchymal Stromberg Cells Treatment: A Systematic Review"
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.